BioMed X has initiated its new research project ‘Regulatory T Cell Dysfunction in Autoimmunity and Inflammaging’ (TDA) in collaboration with Merck KGaA, Darmstadt, Germany.   The main objective of the research group TDA is to understand the molecular mechanisms governing immune senescence and metabolic dysfunction in regulatory T cells and other T cell subsets that are shared in autoimmunity and aging.   Group leader of team TDA, Dr. Gorjana Rackov, explains, “Regulatory T cells (Tregs) are ...